This brand name is authorized in Brazil, Estonia, Finland, Hong Kong, Lithuania, Malta, New Zealand, Romania, Singapore, United Kingdom, South Africa
The drug ADDAVEN contains a combination of these active pharmaceutical ingredients (APIs):
1
Chromic chloride hexahydrate
UNII KB1PCR9DMW - CHROMIC CHLORIDE
|
|
2
Copper chloride dihydrate
UNII P484053J2Y - CUPRIC CHLORIDE ANHYDROUS
|
|
3
Ferric chloride hexahydrate
UNII U38V3ZVV3V - FERRIC CHLORIDE
|
|
4
Manganese chloride tetrahydrate
UNII QQE170PANO - MANGANESE CHLORIDE
|
Manganese is required for the synthesis of the mucopolysaccharides of cartilage, glucose utilisation, steroid biosynthesis and for the activity of pyruvate carboxylase. It is bound to arginase of the liver and activates many enzymes. |
5
Potassium iodide
UNII 1C4QK22F9J - POTASSIUM IODIDE
|
Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities. |
6
Sodium fluoride
UNII 8ZYQ1474W7 - SODIUM FLUORIDE
|
Sodium fluoride is indicated for the prevention of dental caries in adolescents and adults, particularly amongst patients at risk from multiple caries (coronal and/or root caries). The primary mode of the caries preventative action of fluoride is post-eruptive, i.e topical action. Systemic fluoride supplements are believed also to act mainly topically (i.e during ingestion, via saliva). |
7
Sodium molybdate
UNII 8F2SXI1704 - SODIUM MOLYBDATE DIHYDRATE
|
|
8
Sodium selenite anhydrous
UNII HIW548RQ3W - SODIUM SELENITE
|
Selenium is an essential trace element. In human, selenium compounds are glutathione peroxidase and a selenium protein P found in the plasma. Deficiency of selenium has been associated with an endemic form of cardiomyopathy, Keshan disease and with Kaschin-Beck disease, an endemic osteoarthropathy which causes a severe deformity of the joints. |
9
Zinc chloride
UNII 86Q357L16B - ZINC CHLORIDE
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
B05XA31 | Electrolytes in combination with other drugs | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05X I.V. solution additives → B05XA Electrolyte solutions |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 509520120028007 |
Country: EE | Ravimiamet | Identifier(s): 1607172 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 497556 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 377629 |
Country: HK | Department of Health Drug Office | Identifier(s): 64379 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1069565 |
Country: MT | Medicines Authority | Identifier(s): MA1123/01901 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 6223 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66283001 |
Country: SG | Health Sciences Authority | Identifier(s): 15302P |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 49/24/0996 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.